跳至主要内容
临床试验/CTRI/2018/09/015825
CTRI/2018/09/015825尚未招募4 期

Phase IV, Open-Label, Randomized, Parallel-Group, Comparative Study of Feracrylum Gel and Cetrimide Cream on Minor Traumatic Wounds in Non-Hospitalized Patients

Themis Medicare Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. Patients who have minor traumatic wounds such as cuts, abrasions, lacerations caused by road traffic accidents and other causes
  • 2. Patients who provide a signed informed consent to abide by the study requirements

排除标准

  • 1. Patients with life threatening injuries
  • 2. Patients requiring wound suturing and hospitalization
  • 3. Patients with pulse >100/min, Systolic BP < 90mm Hg or respiratory rate beyond 10-29/min
  • 4. Patients with altered sensorium (Glasgow coma scale of <15)
  • 5. Patients with severe bleeding or suspected internal hemorrhage
  • 6. Patients with fractures
  • 7. Patients with suspected internal injury to head, chest, abdomen, pelvis, spine or long bones
  • 8. Patients with HIV, cardiac, hepatic, gastrointestinal, renal, pulmonary and skin diseases
  • 9. Pregnant and lactating women
  • 10. Known hypersensitivity to any of the ingredients of the test / comparator formulation
  • 11. Simultaneous participation in another clinical study

研究者

相似试验

已完成
4 期
A clinical trial to assess and compare the safety of Pentavac Vaccine (DTP-HB+Hib) of SIIL with Tritanrix-HB-HIB of GSK in Indian infants.
CTRI/2009/091/000615Serum Institute of India Research Foundation1,500
尚未招募
不适用
Open-label, randomised, 4 parallel-group, Phase I clinical trial to investigate BI 456906 occupancy of Glucagon receptors in liver and Glucagon-like Peptide 1 receptors in pancreas in comparison with semaglutide after administration of radiolabeled tracer in male and female subjects with obesity using PET and MRIobesityObesity
NL-OMON56752Boehringer Ingelheim30
进行中(未招募)
不适用
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In InfantsMeningococcal disease causes high rates of morbidity and mortality even among patients who receive early antibiotic treatment.
EUCTR2014-004605-33-Outside-EU/EEAovartis Vaccines & Diagnostics, Inc.4,500
进行中(未招募)
不适用
A Phase 3, Randomized, Open-label, Parallel-group, Multicenter Trial to Evaluate the Safety and Efficacy of Infliximab (REMICADE®) in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitislcerative colitisMedDRA version: 8.1Level: LLTClassification code 10045365Term: Ulcerative colitis
EUCTR2006-000410-20-DKCentocor BV60
进行中(未招募)
不适用
A Phase 3, Randomized, Open-label, Parallel-group, Multicenter Trial to Evaluate the Safety and Efficacy of Infliximab (REMICADE®) in Pediatric Subjects with Moderately to Severely Active Ulcerative Colitislcerative colitisMedDRA version: 8.1Level: LLTClassification code 10045365Term: Ulcerative colitis
EUCTR2006-000410-20-BECentocor BV40